Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine

Ha Won Kim1, Andra L Blomkalns2, Mourad Ogbi1

  • 1Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia.

Insights

Myeloperoxidase (MPO) drives abdominal aortic aneurysm (AAA) formation. Deleting the MPO gene or supplementing with taurine prevented AAA in animal models, suggesting MPO and taurine as potential therapeutic targets for AAA.

Area of Science:

  • Biochemistry
  • Pathology
  • Pharmacology

Background:

  • Oxidative stress is crucial in abdominal aortic aneurysm (AAA) development.
  • Neutrophils, expressing myeloperoxidase (MPO), are linked to AAA pathogenesis.
  • MPO's role in AAA formation was previously uninvestigated.

Purpose of the Study:

  • To investigate the role of myeloperoxidase (MPO) in abdominal aortic aneurysm (AAA) formation.
  • To evaluate the therapeutic potential of taurine in preventing AAA.

Main Methods:

  • MPO gene deletion in mouse models of AAA (ANG II infusion, elastase perfusion).
  • Oral administration of taurine in AAA mouse models (ANG II, elastase, CaCl2).
  • Assessment of AAA formation, aortic MPO activity, oxidative stress markers, inflammation, and matrix degradation.

Main Results:

  • MPO gene deletion significantly attenuated AAA formation in both models.
  • Taurine administration prevented AAA formation and reduced MPO activity and oxidative stress.
  • Both interventions reduced macrophage accumulation, elastin fragmentation, matrix metalloproteinase activation, and serum amyloid A induction.

Conclusions:

  • Myeloperoxidase (MPO) plays a critical role in abdominal aortic aneurysm (AAA) pathogenesis.
  • Taurine effectively prevents AAA formation by scavenging MPO-generated oxidants.
  • Targeting MPO or utilizing taurine may offer a novel therapeutic strategy for AAA.